REQUEST A DEMO
Total
USD $0.00
Search more companies

Scala Clinical Research SRL (Romania)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Scala Clinical Research SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Scala Clinical Research SRL is an enterprise located in Romania, with the main office in Bucharest. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. It was incorporated on March 22, 2012. It currently has a total number of 1 (2020) employees. The company’s latest financial report indicates a net sales revenue drop of 85.74% in 2022. Its’ total assets recorded a negative growth of 7.29%. Scala Clinical Research SRL’s net profit margin decreased by 9.48% in 2022.

Headquarters
Strada Maresal Alexandru Averescu Nr. 11
Bucharest; Bucharest; Postal Code: 011454

Contact Details: Purchase the Scala Clinical Research SRL report to view the information.

Basic Information
Total Employees:
Purchase the Scala Clinical Research SRL report to view the information.
Outstanding Shares:
Purchase the Scala Clinical Research SRL report to view the information.
Registered Capital:
Purchase the Scala Clinical Research SRL report to view the information.
Incorporation Date:
March 22, 2012
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Scala Clinical Research SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-85.74%
Total operating revenue
-71.95%
Operating profit (EBIT)
-86.14%
EBITDA
-77.15%
Net Profit (Loss) for the Period
-88.19%
Total assets
-7.29%
Total equity
-22.14%
Operating Profit Margin (ROS)
-1.68%
Net Profit Margin
-9.48%
Return on Equity (ROE)
-25.49%
Quick Ratio
-6.43%
Cash Ratio
-1.94%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?